2025 Annual Report

In 2025, IASLC made great strides globally in research, member engagement, education, investment, and more. IASLC is a leader in the global thoracic malignancy community and advances its mission to be the multidisciplinary world authority on lung and other thoracic cancers through collaborative science, education, and advocacy in order to ensure optimal prevention and patient care.